StockGuru Spotlight October 13, 2010
WYNX, IVDA, CDXC, ECNG, GHLV, COWI, CBIS
Dear Members:
StockGuru picks triple digit winners all the time. We take a closer look at stocks making a move, sometimes with reason and sometimes without.
Synergy Pharmaceuticals, Inc. (OTCBB: SGYP) has a market cap of $446M and is trading in the $4.00 range, with an admitted overhang of 400,000 warrants at $2.75 and a recent sale of 1M shares at $2.50 – but considering the market cap, that was not a problem for long. It did knock the socks off this stock for a while, but it is climbing back out. Bottom line: they can raise cash and that is never a bad thing.
SGYP is a developer of new drugs to treat gastrointestinal disorders and diseases, and recently announced positive results in a Phase IIa clinical trial. The clinical data will be presented on Monday, October 18, 2010 at the American College of Gastroenterology Annual Scientific meeting in San Antonio, Texas. That should give this stock a little kick. This is a good company, sufficiently funded with excellent accountants and attorneys.
Admittedly, this stock is only up 13% since the StockGuru Spotlight — not one of our fastest movers, but this is a good Bio-tech Company with a strong market cap and ought to see some additional interest after the San Antonio Meeting. Doctors like to invest. Check out the SGYP PowerPoint filed as an 8-K: SGYP PowerPoint Presentation
YouChange Holdings Corp (OTCBB:YCNG) has made a nice move since it was first placed in the StockGuru Spotlight — and there is no clear reason why it is moving. Watch it — is the word. See what happens and look for news.
StockGuru Spotlight Picks Trading AT Highs Yesterday
See our chart below but check these out:
- FMTP 182%
- MXSG 211%
- EVSI 67%
- RLGT 61%
- WOVT 59%
- CSGH 55%
- CPYE 53%
- QPSA 50%
We have triple digit winners every day, but here is where you find triple digit winners in the making:
SGYP Picked at Low Point of $4.40
SGYP Press Release StockGuru SGYP
Synergy Pharmaceuticals, Inc. (OTCBB: SGYP), is developer of new drugs to treat gastrointestinal disorders and diseases which recently announced today positive results in a Phase IIa clinical trial of plecanatide (SP-304) in patients with chronic constipation.
SGYP Financing Agreements Impacting Price:
On October 1, 2010, Synergy Pharmaceuticals, Inc., a Florida corporation (the “Company”), entered into a securities purchase agreement with a non-U.S. investor to raise gross proceeds of $2,500,000 in a registered direct offering. The Company will issue to the investor 1,000,000 shares of its common stock and warrants to purchase 400,000 shares of common stock. The purchase price paid by the investor was $2.50 for each unit. The warrants expire after five years and are exercisable at $2.75 per share.
On August 16, 2010, Synergy Pharmaceuticals, Inc. (the “Company”) entered into a securities purchase agreement with an accredited investor to sell securities and raise gross proceeds of $400,000 in a private placement. The Company sold 98,765 units to the investor with each unit consisting of one share of the Company’s common stock and one warrant to purchase one additional share of the Company’s common stock. The purchase price paid by the investor was $4.05 for each unit. The warrants expire after five years and are exercisable at $4.25 per share.
YCNG STOCKGURU SPOTLIGHT September 17, 2010 at $0.20
Closed Yesterday at $0.32
This Gives You a Nice StockGuru Spotlight Return of 60%
YCNG Press Release YCNG StockGuru Spotlight
YouChange Holdings Corp (OTCBB:YCNG) has not put out any news since its September 16, 2010, announcement of the launch of the company’s electronic recycling, rewards and buyback website. It has changed accounting firms and filed a notice of late filing. Not really sure why this one is moving up. Watch it and see what happens.
Today’s Spotlight Highlights
Yellow Highlights Indicate Trading at High Since Spotlight or Just a Few Percentage Points from the High
Date | Pick Price | Stock | High | Up As Much As | Market Cap | |
Aug | 18 | $ 0.14 | BFRE | $ 0.76 | 439% | 18.27M |
Aug | 31 | $ 0.05 | PVHO | $ 0.20 | 300% | 3.24M |
Aug | 9 | $ 0.17 | FMTI | $ 0.48 | 182% | 2.34M |
Jun | 25 | $ 0.32 | SKPI | $ 0.95 | 197% | 51.74M |
Sep | 1 | $ 0.09 | MXSG | $ 0.28 | 211% | 31.83M |
Jul | 13 | $ 0.87 | ROHI | $ 1.90 | 118% | 46.06M |
Jul | 29 | $ 0.06 | SMME | $ 0.16 | 166% | 10.15M |
Jul | 2 | $ 0.30 | VUOC | $ 0.90 | 200% | 44.80M |
Aug | 27 | $ 0.25 | GLXZ | $ 0.45 | 88% | 14.85M |
Jul | 1 | $ 0.35 | LBRG | $ 0.70 | 100% | 66.79M |
Aug | 30 | $ 0.30 | VKNG | $ 0.50 | 67% | 26.08M |
Sep | 1 | $ 0.27 | EVSI | $ 0.45 | 67% | 17.83M |
Sep | 7 | $ 0.26 | ZERO see disclosure | $ 0.42 | 62% | 34.65M |
Sep | 8 | $ 0.07 | BFDI | $ 0.12 | 71% | 4.21M |
Aug | 18 | $ 0.30 | IDLM | $ 0.51 | 70% | 26.90M |
Jun | 18 | $ 1.35 | WOVT | $ 2.14 | 59% | 124.04M |
Jun | 17 | $ 1.21 | TURV | $ 1.89 | 55% | 21.40M |
Jun | 25 | $ 3.01 | MASC | $ 5.24 | 74% | 57.43M |
Aug | 20 | $ 0.20 | AREM | $ 0.30 | 50% | 6.38M |
Sep | 20 | $ 0.02 | CVNS | $ 0.03 | 50% | 3.76M |
Aug | 2 | $ 0.10 | PHLI | $ 0.19 | 90% | 2.37M |
Jun | 18 | $ 1.35 | SFES | $ 2.00 | 48% | 45.88M |
Jul | 27 | $ 1.25 | TURV | $ 1.85 | 48% | 21.40M |
Aug | 13 | $ 0.38 | AOLS | $ 0.57 | 50% | 33.56M |
Jul | 8 | $ 0.24 | TAMO | $ 0.64 | 167% | 26.66M |
Aug | 16 | $ 2.05 | CECX | $ 3.07 | 50% | 64.18M |
Jul | 9 | $ 0.08 | PTSC | $ 0.26 | 225% | 44.94M |
Aug | 30 | $ 0.74 | CSGH | $ 1.15 | 55% | 61.44M |
Aug | 13 | $ 0.28 | RLGT | $ 0.45 | 61% | 13.45M |
Aug | 4 | $ 3.80 | QPSA | $ 6.00 | 58% | 68.91M |
Sep | 10 | $ 0.60 | LPTN | $ 0.90 | 50% | 42.48M |
Jun | 25 | $ 0.49 | NENE | $ 0.79 | 61% | 36.33M |
Jul | 6 | $ 3.85 | QPSA | $ 5.70 | 50% | 74.81M |
Jul | 12 | $ 0.05 | NEON | $ 0.07 | 40% | 29.29M |
Aug | 13 | $ 0.54 | RBYC | $ 0.78 | 44% | 11.66M |
Jul | 29 | $ 1.11 | DAFX | $ 2.30 | 107% | 90.64M |
Aug | 25 | $ 0.07 | CPYE | $ 0.11 | 53% | 2.68M |
Aug | 2 | $ 0.63 | LPTN | $ 0.95 | 51% | 42.48M |
Aug | 6 | $ 1.50 | LXUN | $ 2.00 | 33% | 17.66M |
Jul | 7 | $ 5.90 | BOBS | $ 7.80 | 32% | $ – |
Jun | 14 | $ 0.43 | FEEC | $ 0.58 | 35% | 103.98M |
Jul | 16 | $ 1.22 | XTGR | $ 1.70 | 39% | 54.49M |
Get On Board – the Stock Guru Trading Way
We are NOT compensated in any way for these Spotlight Picks. If we decide to include a pick for which we are compensated you will be clearly informed. StockGuru Spotlights While you can never catch the exact high StockGuru shows you the potential when you learn to trade the StockGuru Way. We look at the news that moves the stocks — good and bad. StockGuru brings you trading news you can use and meaningful trends.
Our StockGuru Spotlight Picks Are Published Before the Open Each Morning StockGuru Spotlights are featured on our web site. We have an RSS feed and an exclusive twitter feed for StockGuru Spotlights. We also issue press releases on the StockGuru Spotlights; you can see proof positive our notice to you is truly an advanced notice. StockGuru is not not jumping on these after they move. Here is the link to BOOKMARK for Spotlights: http://stockguru.com/tag/spotlight Don’t Miss Our on Spotlight Stocks! It is critical to catch these alerts in the morning prior to the market open. I have been asked several times recently how to get them.
IMPORTANT: Bookmark this link: http://stockguru.com/tag/spotlight Check This Link Every Morning for New Spotlight Stocks All of these are date and time stamped so you know what is current today. You can also just go to STOCKGURU.COM and look for the link in the top navigation for “StockGuru Spotlight.” You can also put the RSS link into your RSS reader, such as my favorite “Google Reader.”
There are countless programs that make it easy to get RSS feeds on your wireless phone as well. This is foolproof BUT ONLY IF YOU CHECK YOUR RSS FEED REGULARLY! RSS link on the site. We do not yet send out Spotlight Alerts by email, in an attempt to give your email box a break. Spotlights occur several times weekly, and are released ONLY when we see a valid reason. Occasionally, our Spotlights are compensated picks, but an editorial decision is made as to whether the situation qualifies as a market sensitive pick and we ALWAYS include a disclosure prominently if we include a company for which we have been compensated in either cash or shares.
StockGuru is in its Eighth Year!
OTCBB: ZERO or STWA, Inc. Disclosure: StockGuru was compensated 60,000 144 restricted common shares by the company for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. We currently hold no shares and have taken no additional shares, nor have we purchases any in the market. To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program or during any time thereafter when our activities might impact the value of the shares. This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. We hold no shares and will not be receiving further compensation in shares or that is share while we are covering this company. StockGuru is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. Our contact information is Pentony Enterprises; 1601 Berwick Drive; McKinney, Texas 75070; Telephone 469-252-3030.